Literature DB >> 10465375

Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy.

I Björn1, T Bäcksröm.   

Abstract

OBJECTIVES: The reasons for poor compliance with hormone replacement therapy (HRT) and, in particular drug-related reasons, have not yet been fully elucidated. In this study, a cohort of peri- or postmenopausal women--mainly workers from a small town and surrounding rural area--was studied. The aim of the study was to investigate why some women never start or discontinue HRT, even when great effort has been made to inform and fulfill the demands of the patient.
METHODS: All women who were given a HRT prescription at a gynecological practice between September 1991 and December 1992 participated in a longitudinal study. A written questionnaire was mailed to these patients in 1996. Data from the questionnaire was supplemented with information from the medical records. Care of patients included initial information, follow-up within 4 months, yearly visits supplemented with contacts on demand.
RESULTS: 356 women received the questionnaire, among which 92% replied. A total of 2% never started HRT. Seventy-five percent continued the therapy for more than 3 years. Reasons for discontinuing HRT were negative side-effects (35%), desire to find out if climacteric symptoms had ended (26%), fear of cancer and thrombosis (25%), weariness of bleeding (19%) and a wish to deal with the problems 'naturally' (15%).
CONCLUSIONS: Compliance with HRT can be high if adequate information is given and follow-ups are made. The main reason for poor compliance was negative side-effects, most likely progestin-related. The results of this study suggest that the future challenge will be to minimize negative side-effects of HRT.

Entities:  

Mesh:

Year:  1999        PMID: 10465375     DOI: 10.1016/s0378-5122(99)00018-3

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  8 in total

1.  Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone.

Authors:  Lotta Andréen; Inger Sundström-Poromaa; Marie Bixo; Sigrid Nyberg; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2006-05-25       Impact factor: 4.530

Review 2.  Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.

Authors:  Anna-Carin N-Wihlbäck; Inger Sundström-Poromaa; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

Review 3.  Monitoring drug adherence.

Authors:  Sarah R Lieber; Jacqueline Helcer; Eyal Shemesh
Journal:  Transplant Rev (Orlando)       Date:  2015-04       Impact factor: 3.943

4.  Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2006-08

5.  Progesterone enhances performance of aged mice in cortical or hippocampal tasks.

Authors:  Cheryl A Frye; Alicia A Walf
Journal:  Neurosci Lett       Date:  2008-04-07       Impact factor: 3.046

6.  The Effect of Foeniculum Vulgare (Fennel) on Body Composition in Postmenopausal Women with Excess Weight: A Double-blind Randomized Placebo-controlled Trial.

Authors:  Nafiseh Saghafi; Masumeh Ghazanfarpour; Talat Khadivzadeh; Masoudeh Babakhanian; Maliheh Afiat
Journal:  J Menopausal Med       Date:  2017-12-29

7.  Effects of Phytoestrogens in Alleviating the Menopausal Symptoms: A Systematic Review and Meta-Analysis.

Authors:  Nafiseh Saghafi; Masoumeh Ghazanfarpour; Ramin Sadeghi; Azadeh Hosseini Najarkolaei; Maryam Ghaffarian Omid; Afrooz Azad; Mahmood Bakhtiyari; Elnaz Hosseini Najarkolaei
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

8.  Influence of female sex hormones on periodontium: A case series.

Authors:  Zeba Jafri; Ashu Bhardwaj; Madhuri Sawai; Nishat Sultan
Journal:  J Nat Sci Biol Med       Date:  2015-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.